Coya Therapeutics | ARS: Annual Report to Security Holders
Coya Therapeutics | DEFA14A: Others
Coya Therapeutics | DEF 14A: Definitive information statements
Coya Therapeutics | 10-K: Annual report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee Ann
Coya Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Einhorn(8.8%),DME Advisors GP, LLC(5.8%), etc.
Coya Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AIGH Investment Partners, L.L.C.(.9%),Orin H(8.1%), etc.
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grossman Fred
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SNYDER DAVID S
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Berman Howard
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Weinand Dieter
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Garren Hideki
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOLDSTEIN DOV A MD
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee Ann
Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Villalobos Anabella
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 424B3: Prospectus
Coya Therapeutics | EFFECT: Others
Coya Therapeutics | CORRESP: CORRESP
No Data